Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Management of Gravidocardiac Disease in Pregnancy

Risk Assessment and Diagnosis

  • The European Society of Cardiology recommends that all women with cardiac diseases should undergo risk assessment before conception and immediately after pregnancy is confirmed 2
  • Echocardiography should be performed in any pregnant patient with unexplained or new cardiovascular signs or symptoms, as recommended by the European Society of Cardiology 2
  • MRI without gadolinium should be considered if echocardiography is insufficient for diagnosis, according to the European Society of Cardiology 2, 3
  • Chest radiography with fetal shielding may be considered when other methods fail to clarify the cause of dyspnea, as suggested by the European Society of Cardiology 2, 3
  • Cardiac catheterization may be considered with strict indications and proper shielding of the fetus, as recommended by the European Society of Cardiology 2, 3

High-Risk Cardiac Conditions in Pregnancy

  • Pulmonary hypertension carries a high maternal mortality risk (17-33% in recent studies), according to the European Society of Cardiology 2
  • Severe left-sided obstructions (mitral stenosis, aortic stenosis) can cause problems even when asymptomatic before pregnancy, as noted by the European Society of Cardiology 1
  • Dilated poorly functioning left ventricles and fragile aortas (as in Marfan syndrome) are dangerous conditions during pregnancy, according to the European Society of Cardiology 1
  • Women in NYHA functional class III or IV have significantly higher risk, as reported by the European Society of Cardiology 1
  • Peripartum cardiomyopathy (PPCM) requires special attention with a reported mortality rate of 6-27.6%, according to the European Society of Cardiology 4

Management During Pregnancy

  • High-risk patients should be monitored by a multidisciplinary team including cardiologists, obstetricians, and anesthesiologists, as recommended by the European Society of Cardiology 2
  • Medication management must consider both maternal and fetal effects: ACE inhibitors, ARBs, and renin inhibitors are contraindicated during pregnancy, while beta-blockers and low-dose aspirin are considered relatively safe, according to the European Society of Cardiology 5
  • Regular assessment of maternal cardiac status and fetal well-being throughout pregnancy is essential, as noted by the European Journal of Heart Failure 4
  • Continuous invasive hemodynamic monitoring may be necessary for women with severe cardiac disease, as recommended by the European Journal of Heart Failure 4

Labor and Delivery Planning

  • Vaginal delivery is recommended as first choice in most patients with cardiac disease, according to the European Society of Cardiology 2, 7
  • Spontaneous onset of labor is appropriate for women with normal cardiac function, as suggested by the European Society of Cardiology 7
  • For induced labor with favorable Bishop score, oxytocin and artificial rupture of membranes are indicated, as recommended by the European Society of Cardiology 7
  • Epidural analgesia is preferred during labor as it stabilizes cardiac output, according to the European Journal of Heart Failure 4
  • Caesarean delivery should be considered for patients with specific high-risk conditions, such as dilatation of ascending aorta >45 mm, severe aortic stenosis, or Eisenmenger syndrome, as recommended by the European Society of Cardiology 2

Intrapartum Management

  • Continuous monitoring of maternal vital signs and fetal heart rate is essential, as noted by the European Journal of Heart Failure 4
  • Positioning in lateral decubitus or sitting-up position as needed for cardiac status, as suggested by the European Journal of Heart Failure 4
  • Avoid fluid overload during intravenous infusions, as recommended by the European Journal of Heart Failure 4
  • For the third stage, a single dose of intramuscular oxytocin is recommended; ergometrine is contraindicated, according to the European Journal of Heart Failure 4

Postpartum Care

  • Close monitoring for at least 24-48 hours after delivery due to significant hemodynamic changes, as noted by the European Journal of Heart Failure 4
  • Auto-transfusion of blood from the lower limbs and contracted uterus may significantly increase preload, as reported by the European Journal of Heart Failure 4
  • A single IV dose of furosemide is commonly given after delivery to manage increased preload, according to the European Journal of Heart Failure 4
  • Anticoagulants should be restarted in consultation with the obstetrician and anesthesiologist when post-partum bleeding has stopped, as recommended by the European Journal of Heart Failure 4
  • For patients with PPCM, breastfeeding may not be advised due to potential negative effects of prolactin subfragments, as noted by the European Journal of Heart Failure 4

Special Considerations

  • For acute coronary syndrome during pregnancy, primary PCI is preferred over thrombolysis, as recommended by the European Society of Cardiology 5
  • Bare metal stents are preferred over drug-eluting stents during pregnancy, according to the European Society of Cardiology 5